Effects of nursing team communication and collaboration on treatment outcomes in intensive care unit patients with severe pneumonia

Table 1 General patient information, mean ± SD

Group	Experimental group	Control group	F/t	P value
Age (yr)	54.73 ± 5.31	65.5 ± 3.15	-0.722	0.473
Gender (Male/female)	13/17	14/ 16	0.591	0.444
Body mass index	24.27 ± 1.81	23.85 ± 2.13	0.808	0.421
Smoking history (pack/yr)	16/14	15/ 14	0.644	0.425
High blood pressure (Yes/No)	14/16	13/17	0.586	0.446
Diabetes (Yes/No)	8/22	7/23	0.586	0.446
Glycosylated hemoglobin (%)	5.37 ± 0.68	5.62 ± 0.72	-1.090	0.280
Total cholesterol (mmoL/L)	6.39 ± 0.68	6.40 ± 0.72	-0.069	0.944
Triglyceride (mmoL/L)	1.43 ± 0.49	1.58 ± 0.42	-1.284	0.203
Low density lipoprotein (mmoL/L)	3.06 ± 0.55	3.27 ± 0.45	-1.600	0.114
Phospholipid protein A1 (g/L)	0.95 ± 0.21	0.87 ± 0.17	1.592	0.116
Phospholipid protein B (g/L)	1.46 ± 0.35	1.42 ± 0.36	0.431	0.667
Lipoprotein (mg/dL)	127.14 ± 7.93	134.31 ± 9.39	-1.927	0.058

Table 2 Comparison of respiratory mechanics indicators before treatment, mean ± SD

Group	Time	Cst (mL/cm H2O)	Raw (cm H2O/L/s)	mPaw (cm H2O)	Pplat (cm H2O)	PIP (cm H2O)
Test group	Before treatment	44.39 ± 3.87	15.63 ± 2.18	18.21 ± 3.17	24.33 ± 3.69	26.20 ± 4.87
	After treatment	51.97 ± 4.84	12.26 ± 1.64	15.90 ± 2.37	21.44 ± 3.01	24.06 ± 3.12
Control group	Before treatment	44.00 ± 3.58	15.86 ± 1.80	18.80 ± 2.71	24.51 ± 2.71	26.33 ± 4.15
	After treatment	49.49 ± 4.47	14.80 ± 1.99	18.72 ± 2.03	24.50 ± 3.12	27.81 ± 4.03
t/P (before and after treatment)		0.404/0.688	-0.449/0.655	-0.774/0.442	-0.215/0.83	-0.111/0.912
t/P (before and after treatment)		2.06/0.044	-0.541/< 0.01	-4.954/< 0.01	-3.871/< 0.01	-4.027/< 0.01

Cst: Respiratory system static compliance; Raw: Airway resistance; mPaw: Mean airway pressure; Pplat: Plateau pressure; PIP: Peak pressure.

Table 3 Comparison of blood gas analysis indicators before treatment, mean ± SD

Group	Time	SpO2 (%)	PaO2 (mmHg)	OI
Test group	Before treatment	93.15 ± 1.79	80.24 ± 7.15	18.58 ± 2.50
	After treatment	94.68 ± 1.68	92.53 ± 8.13	15.28 ± 1.99
Control group	Before treatment	93.34 ± 2.16	78.78 ± 7.28	19.35 ± 2.57
	After treatment	93.52 ± 2.32	86.65 ± 6.15	18.16 ± 1.75
t/P (before and after treatment)		-0.37/0.713	0.786/0.435	-1.19/0.239
t/P (before and after treatment)		2.231/0.03	3.159/< 0.01	-5.952/< 0.01

SpO₂: Blood oxygen saturation; PaO₂: Arterial partial pressure of oxygen; OI: Oxygenation index.

Table 4 Comparison of serum inflammatory factor levels before treatment, mean ± SD

Group	Time	CRP (mg/L)	PCT (ng/mL)
Test group	Before treatment	41.98 ± 4.45	2.43 ± 0.81
	After treatment	40.29 ± 3.38	2.46 ± 0.64
Control group	Before treatment	41.83 ± 2.07	1.16 ± 0.5
	After treatment	29.53 ± 5.03	2.40 ± 0.48
t/P (before and after treatment)		0.163/0.871	0.451/0.654
t/P (before and after treatment)		9.732/< 0.01	7.259/< 0.01

CRP: C-reactive protein; PCT: Procalcitonin.

Table 5 Changes in serum cortisol and high mobility group protein B1 levels, mean ± SD

Group	Time	COR (μg/dL)	HMGB1 (ng/mL)
Test group	Before treatment	19.33 ± 2.30	32.20 ± 3.27
	After treatment	14.94 ± 2.19	28.30 ± 2.58
Control group	Before treatment	18.65 ± 2.36	33.70 ± 2.98
	After treatment	18.25 ± 2.25	33.17 ± 3.05
t/P (before and after treatment)		1.125/0.265	-1.742/0.087
t/P (before and after treatment)		-5.77/< 0.01	-6.684/< 0.01

COR: Cortisol; HMGB1: High mobility group protein B1.